BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27799390)

  • 21. [Clinicopathologic correlation and ALK rearrangement in adenocarcinoma of lung].
    Liu P; Wang C; Wu S; Gao J; Zeng X
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):241-5. PubMed ID: 24915814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residential radon and lung cancer among never-smokers in Sweden.
    Lagarde F; Axelsson G; Damber L; Mellander H; Nyberg F; Pershagen G
    Epidemiology; 2001 Jul; 12(4):396-404. PubMed ID: 11416777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 Mutations in lung cancer associated with residential radon exposure.
    Yngveson A; Williams C; Hjerpe A; Lundeberg J; Söderkvist P; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):433-8. PubMed ID: 10350439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR-TKI and crizotinib in relation to diverse receptors phosphorylation.
    Yang JJ; Zhang XC; Su J; Xu CR; Zhou Q; Tian HX; Xie Z; Chen HJ; Huang YS; Jiang BY; Wang Z; Wang BC; Yang XN; Zhong WZ; Nie Q; Liao RQ; Mok TS; Wu YL
    Clin Cancer Res; 2014 Mar; 20(5):1383-92. PubMed ID: 24443522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients.
    Martín Martorell P; Huerta M; Compañ Quilis A; Abellán R; Seda E; Blesa S; Chaves FJ; Dualde Beltrán D; Roselló Keränen S; Franco J; Insa A
    Clin Lung Cancer; 2017 Nov; 18(6):e395-e402. PubMed ID: 28550959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.
    Sasaki H; Endo K; Takada M; Kawahara M; Kitahara N; Tanaka H; Okumura M; Matsumura A; Iuchi K; Kawaguchi T; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Lung Cancer; 2006 Oct; 54(1):103-8. PubMed ID: 16890322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer].
    Wang X; Zhong D
    Zhongguo Fei Ai Za Zhi; 2018 Sep; 21(9):686-691. PubMed ID: 30201068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Residential radon and lung cancer. An ecologic study in Galicia, Spain].
    Barbosa-Lorenzo R; Ruano-Ravina A; Cerdeira Caramés S; Barros-Dios JM
    Med Clin (Barc); 2015 Apr; 144(7):304-8. PubMed ID: 24485165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A large-scale cross-sectional study of ALK rearrangements and EGFR mutations in non-small-cell lung cancer in Chinese Han population.
    Hong S; Fang W; Hu Z; Zhou T; Yan Y; Qin T; Tang Y; Ma Y; Zhao Y; Xue C; Huang Y; Zhao H; Zhang L
    Sci Rep; 2014 Dec; 4():7268. PubMed ID: 25434695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.
    Riely GJ; Pao W; Pham D; Li AR; Rizvi N; Venkatraman ES; Zakowski MF; Kris MG; Ladanyi M; Miller VA
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):839-44. PubMed ID: 16467097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases.
    Boland JM; Jang JS; Li J; Lee AM; Wampfler JA; Erickson-Johnson MR; Soares I; Yang P; Jen J; Oliveira AM; Yi ES
    J Thorac Oncol; 2013 May; 8(5):574-81. PubMed ID: 23449277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- and never-smoking U.S. women.
    Taga M; Mechanic LE; Hagiwara N; Vähäkangas KH; Bennett WP; Alavanja MC; Welsh JA; Khan MA; Lee A; Diasio R; Edell E; Bungum A; Jang JS; Yang P; Jen J; Harris CC
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):988-92. PubMed ID: 22523180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R.
    Ke EE; Zhou Q; Zhang QY; Su J; Chen ZH; Zhang XC; Xu CR; Yang JJ; Tu HY; Yan HH; Zhang YC; Niu FY; Wu YL
    J Thorac Oncol; 2017 Sep; 12(9):1368-1375. PubMed ID: 28576746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
    Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
    Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study.
    Darby S; Whitley E; Silcocks P; Thakrar B; Green M; Lomas P; Miles J; Reeves G; Fearn T; Doll R
    Br J Cancer; 1998 Aug; 78(3):394-408. PubMed ID: 9703290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combined analysis of North American case-control studies of residential radon and lung cancer.
    Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Field RW; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
    J Toxicol Environ Health A; 2006 Apr; 69(7):533-97. PubMed ID: 16608828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect.
    Sahnane N; Frattini M; Bernasconi B; Zappa F; Schiavone G; Wannesson L; Antonelli P; Balzarini P; Sessa F; Mazzucchelli L; Tibiletti MG; Martin V
    Clin Lung Cancer; 2016 Jan; 17(1):56-61. PubMed ID: 26381283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.
    Chung C
    J Oncol Pharm Pract; 2016 Jun; 22(3):461-76. PubMed ID: 25855240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small cell lung cancer in never-smokers.
    Torres-Durán M; Ruano-Ravina A; Kelsey KT; Parente-Lamelas I; Provencio M; Leiro-Fernández V; Abal-Arca J; Montero-Martínez C; Vidal-Garcia I; Pena C; Castro-Añón O; Golpe-Gómez A; Martínez C; Guzmán-Taveras R; Mejuto-Martí MJ; Fernández-Villar A; Barros-Dios JM
    Eur Respir J; 2016 Mar; 47(3):947-53. PubMed ID: 26699724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.